Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder‐carcinoma cell lines
- 9 August 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 62 (4) , 449-456
- https://doi.org/10.1002/ijc.2910620415
Abstract
CD44 core and splice variant exon expression was investigated in the stratified transitional epithelium of the urinary tract and in normal and malignant bladder epithelial cell lines in vitro. Antibodies against core CD44 epitopes and splice exon variants v3, v4/5, v5 and v6 showed an intense reaction in the basal and lower intermediate urothelial cell layers, which was consistently lost from the upper intermediate and superficial cell layers. Seven independent cell lines established from normal human urothelium expressed complex multiple-spliced CD44 mRNA transcripts when tested by RT-PCR and were positive with antibodies against CD44 core epitopes and splice variants v3, v4/5, v5 and v6. Of the 13 bladder-carcinoma cell lines, all were positive for CO44 core. The more differentiated cell lines had retained some splice-variant antibody reactivity and showed multiple but less complex CD44 mRNA transcript patterns, compared with normal cells. Anaplastic cell lines did not react with variant antibodies and did not contain multiple-spliced CD44 transcripts. These data suggest that loss of alternatively-spliced CD44 may reflect a selection pressure in the evolution of anaplastic bladder cancers.Keywords
This publication has 17 references indexed in Scilit:
- Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cellsBMJ, 1994
- Expression and modulation of CD44 variant isoforms in humansThe Journal of cell biology, 1994
- CD44 splice variants; expression on lymphocytes and in neoplasiaResearch in Immunology, 1993
- Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular originThe Journal of cell biology, 1993
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44Science, 1992
- Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.The Journal of Experimental Medicine, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- Monoclonal antibody to a human brain‐granulocyte‐T lymphocyte antigen probably homologous to the W 3/13 antigen of the ratEuropean Journal of Immunology, 1980